The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Address: | Technical University of Denmark, Building 207 |
City: | Lyngby |
State/Province: | |
Postcode: | 2800 |
Country/Region: | Denmark |